HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

LF 16-0687

a potent non-peptide bradykinin B2 receptor antagonist; structure in first source
Also Known As:
1-((2,4-dichloro-3-(((2,4-dimethylquinolin-8-yl)oxy) methyl)phenyl)sulfonyl)-N-(3-((4-(aminoimethyl) phenyl) carbonylamino)propyl)-2(S)-pyrrolidinecarboxamide; Anatibant; LF16-0687; LF16-0687Ms
Networked: 18 relevant articles (2 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Pruneau, D: 6 articles (01/2006 - 01/2000)
2. Pruneau, Didier: 5 articles (05/2006 - 08/2002)
3. Baethmann, A: 4 articles (01/2006 - 01/2000)
4. Plesnila, N: 4 articles (01/2006 - 01/2000)
5. Ivashkova, Yulia: 3 articles (05/2003 - 08/2002)
6. Asa, Ilia: 3 articles (05/2003 - 08/2002)
7. Artru, Alan A: 3 articles (05/2003 - 08/2002)
8. Shapira, Yoram: 3 articles (05/2003 - 08/2002)
9. Ongali, Brice: 2 articles (05/2006 - 12/2005)
10. Marchand-Verrecchia, Catherine: 2 articles (05/2006 - 08/2003)

Related Diseases

1. Brain Edema (Cerebral Edema)
2. Stroke (Strokes)
3. Brain Injuries (Brain Injury)
4. Closed Head Injuries
5. Wounds and Injuries (Trauma)

Related Drugs and Biologics

1. 2,5-dichloro-4-bromophenol (B 2)
2. Bradykinin
3. Bradykinin B2 Receptor
4. Prostaglandins E (PGE)
5. N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))
6. icatibant
7. Dinoprostone (PGE2)
8. Mesylates (Mesylate)
9. LF 16-0687
10. Nitric Oxide Synthase (NO Synthase)

Related Therapies and Procedures

1. Ligation